Cargando…
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Diabetes Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404527/ https://www.ncbi.nlm.nih.gov/pubmed/37533199 http://dx.doi.org/10.4093/dmj.2023.0164 |
| _version_ | 1785085317803409408 |
|---|---|
| author | Ko, Jihee Moon, Sun Joon |
| author_facet | Ko, Jihee Moon, Sun Joon |
| author_sort | Ko, Jihee |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10404527 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Korean Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104045272023-08-08 Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404) Ko, Jihee Moon, Sun Joon Diabetes Metab J Letter Korean Diabetes Association 2023-07 2023-07-27 /pmc/articles/PMC10404527/ /pubmed/37533199 http://dx.doi.org/10.4093/dmj.2023.0164 Text en Copyright © 2023 Korean Diabetes Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Ko, Jihee Moon, Sun Joon Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404) |
| title | Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404) |
| title_full | Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404) |
| title_fullStr | Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404) |
| title_full_unstemmed | Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404) |
| title_short | Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404) |
| title_sort | risk of diabetic retinopathy between sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists (diabetes metab j 2023;47:394-404) |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404527/ https://www.ncbi.nlm.nih.gov/pubmed/37533199 http://dx.doi.org/10.4093/dmj.2023.0164 |
| work_keys_str_mv | AT kojihee riskofdiabeticretinopathybetweensodiumglucosecotransporter2inhibitorsandglucagonlikepeptide1receptoragonistsdiabetesmetabj202347394404 AT moonsunjoon riskofdiabeticretinopathybetweensodiumglucosecotransporter2inhibitorsandglucagonlikepeptide1receptoragonistsdiabetesmetabj202347394404 |